HomeNewsTechnologyCOVID-19 Exposure Notification API from Apple, Google may not work with Aarogya Setu - here is why

COVID-19 Exposure Notification API from Apple, Google may not work with Aarogya Setu - here is why

Upon its release last month, as many as 23 countries had shown interest in using the Exposure Notification API for developing COVID-19 contact-tracing apps.

June 29, 2020 / 10:04 IST
Story continues below Advertisement
Representative image
Representative image

The ‘Exposure Notification’ API developed by Apple and Google for apps to help trace COVID-19 cases has started rolling out in India. The tool was launched in May by both the tech giants for developers to create apps based on the API.

Upon its release, as many as 23 countries showed interest in using the API for developing COVID-19 contact-tracing apps. India already has its own Aarogya Setu COVID-19 contact-tracing app developed by the government.

Story continues below Advertisement

Is the Apple and Google Exposure Notification API compatible with the Aarogya Setu app?

Exposure Notification API is incompatible with Aarogya Setu. There are two reasons for that — The difference in underlying tech and privacy.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show